Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population

  title={Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population},
  author={Bernd L{\"o}we and Oliver Decker and Stefanie Verena M{\"u}ller and Elmar Br{\"a}hler and Dieter Schellberg and Wolfgang Herzog and Philipp Yorck Herzberg},
  journal={Medical Care},
Background:The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a practical self-report anxiety questionnaire that proved valid in primary care. However, the GAD-7 was not yet validated in the general population and thus far, normative data are not available. Objectives:To investigate reliability, construct validity, and factorial validity of the GAD-7 in the general population and to generate normative data. Research Design:Nationally representative face-to-face household survey conducted… 

A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.

Validity and reliability of the Generalized Anxiety Disorder-7 (GAD-7) among university students of Bangladesh

Overall, the study provided support for modified unidimensional structure for GAD-7 and showed high internal consistency along with good convergent validity.

Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study.

  • B. WildAnne Eckl B. Löwe
  • Medicine, Psychology
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2014

The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis.

Findings support the reliability and internal validity of the GAD-7 for use in MS and suggest the need for further anxiety research.

Generalised anxiety disorder in adolescents in Ghana: Examination of the psychometric properties of the Generalised Anxiety Disorder-7 scale

The Generalised Anxiety Disorder-7 (GAD-7) is a self-report scale used to assess general anxiety symptoms. Although the GAD-7 has been found to be a valid scale among adults, studies examining its

The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice

The Spanish version of the GAD-2 scale has been shown to have appropriate psychometric properties to rapidly detect probable cases of GAD in the Spanish cultural context under routine clinical practice conditions.

Factor Structure of The Malay-Version Generalized Anxiety Disorder-7 (GAD-7) Questionnaire among Patients with Diabetes Mellitus

The Malay-version Generalised Anxiety Disorder-7 (GAD-7) questionnaire previously demonstrated good concurrent validity, i.e. sensitivity and specificity as a screening instrument for anxiety.

Psychometric Properties of the General Anxiety Disorder 7-Item (GAD-7) Scale in a Heterogeneous Psychiatric Sample

The GAD-7 has excellent internal consistency, and the one-factor structure in a heterogeneous clinical population was supported, and there was acceptable variation related to treatment groups.



A brief measure for assessing generalized anxiety disorder: the GAD-7.

The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

Although lifetime GAD is highly comorbid, the proportion of current GAD that is not accompanied by any other current diagnosis is high enough to indicate that GAD should be considered an independent disorder rather than exclusively a residual or prodrome of other disorders.

Detecting and monitoring depression with a two-item questionnaire (PHQ-2).

The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener

The construct and criterion validity of the PHQ-2 make it an attractive measure for depression screening, and likelihood ratio and receiver operator characteristic analysis identified a PHZ-2 score of 3 as the optimal cutpoint for screening purposes.

The PHQ-9: validity of a brief depression severity measure.

In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.

Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey

Overall, the results show that DSM‐IV GAD is associated with high impairment even after controlling for other psychopathology, and the impairment outcomes for GAD were comparable in size to those for MDD.

Diagnosing ICD-10 Depressive Episodes: Superior Criterion Validity of the Patient Health Questionnaire

This is the first comparative study to demonstrate the diagnostic advantage of a particular depression-screening instrument using the ICD-10 diagnostic criteria, and the superior criterion validity of the PHQ is likely attributable to its closer representation of the current concept of depressive disorders.

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity, as shown in the recently completed US National Comorbidities Survey Replication.

Generalized anxiety and depression in primary care: prevalence, recognition, and management.

Although the majority of patients with recognized GAD or MDE were treated, only a small minority with GAD were prescribed medications or referred to specialists, which is inconsistent with previous reports that GAD is usually comorbid with depression.